KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Goodwill (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Goodwill data on record, last reported at $1.8 billion in Q4 2025.

  • For Q4 2025, Goodwill changed 0.46% year-over-year to $1.8 billion; the TTM value through Dec 2025 reached $1.8 billion, changed 0.46%, while the annual FY2025 figure was $1.8 billion, 0.46% changed from the prior year.
  • Goodwill reached $1.8 billion in Q4 2025 per EW's latest filing, roughly flat from $1.8 billion in the prior quarter.
  • Across five years, Goodwill topped out at $1.8 billion in Q4 2024 and bottomed at $1.1 billion in Q4 2022.
  • Average Goodwill over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2021.
  • Peak YoY movement for Goodwill: dropped 8.83% in 2022, then soared 54.16% in 2024.
  • A 5-year view of Goodwill shows it stood at $1.2 billion in 2021, then fell by 8.83% to $1.1 billion in 2022, then increased by 8.24% to $1.2 billion in 2023, then soared by 54.16% to $1.8 billion in 2024, then fell by 0.46% to $1.8 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill were $1.8 billion in Q4 2025, $1.8 billion in Q3 2025, and $1.8 billion in Q4 2024.